Market
Lecithin in Denmark is primarily a downstream food-manufacturing ingredient used as the authorised food additive E 322 (lecithins) across multiple product categories. As an EU Member State market, Denmark’s regulatory baseline for lecithin use and labelling is set by EU food additive and food information rules, with national guidance pointing businesses to the EU positive list of permitted E-numbers. Commercial requirements in the Danish market commonly center on documentation for additive identity/purity, allergen (soy) disclosure when soy-derived, and traceability to support buyer audits. Sustainability scrutiny can be material when lecithin is soy-derived due to EU-facing deforestation-risk expectations in upstream soy supply chains.
Market RoleImport-dependent downstream manufacturing market (EU single market)
Domestic RoleWidely used emulsifier ingredient (E 322) for Danish food manufacturing
Risks
Regulatory Compliance HighNon-compliance with EU/Denmark rules for food additives and consumer information (especially soy allergen disclosure for soy-derived lecithin, and additive identity/specification documentation) can trigger border delays, product withdrawal/recall, and loss of approved-supplier status in Denmark.Maintain a Denmark/EU-ready dossier per SKU (E 322 identity/spec, batch CoA, allergen statement aligned to EU allergen rules, and traceability records) and run pre-release label checks for finished foods.
Food Safety MediumSpecification gaps (e.g., impurities/contaminant limits and microbiological criteria where relevant) can lead to non-conformity findings during customer audits or official controls in Denmark/EU.Use suppliers with strong GMP/HACCP systems and align purchasing specs and CoA parameters to EU additive specification frameworks and EFSA-identified data expectations.
Sustainability MediumSoy-derived lecithin may be scrutinized for deforestation-linked sourcing; tightening EU-facing deforestation governance and buyer policies can create commercial exclusion risk without credible origin documentation.Offer soy-origin transparency (country/region where available), adopt deforestation-risk screening for soy supply chains, and secure third-party sustainability attestations where demanded by Danish/EU buyers.
Logistics LowLead-time variability for extra-EU shipments (container capacity or routing disruptions) can cause production interruptions for Danish manufacturers when single-sourced.Dual-source within the EU where feasible and hold safety stock sized to supplier lead-time variability.
Sustainability- Soy-derived lecithin can carry upstream deforestation and land-use change risk exposure in soy supply chains; Danish/EU buyers may require deforestation-risk screening and origin documentation as part of supplier approval.
- Regulatory and buyer-driven deforestation due-diligence expectations for relevant commodity supply chains can tighten documentation requirements and constrain sourcing options.
Labor & Social- Upstream human-rights and labor-risk screening may be requested by Danish buyers for soy-origin supply chains (e.g., supplier codes of conduct, third-party audits) even when Denmark is only a downstream user market.
Standards- FSSC 22000
- ISO 22000
- BRCGS Food Safety
FAQ
Is lecithin permitted for use in foods in Denmark?Yes. Lecithins are authorised as the food additive E 322 under EU food additive rules, which apply in Denmark, and Danish guidance notes that only additives on the EU list of E-numbers may be used.
If lecithin is soy-derived, does it raise allergen labelling obligations in Denmark?It can. EU consumer information rules list soybeans and products thereof as allergens that must be indicated, and Denmark applies these EU labelling requirements; manufacturers should treat soy-derived lecithin as requiring appropriate allergen disclosure unless a specific legal exemption clearly applies.
What official safety assessments exist for lecithins (E 322) in the EU?EFSA has published scientific opinions re-evaluating lecithins (E 322) for the general population and for infant-related uses, concluding no safety concern at assessed exposure scenarios under the reported uses, and international evaluations are also recorded in the WHO/JECFA database.